Epidemiology of pulmonary arterial hypertension.
Progress in understanding the basic biology and the development of new therapies for pulmonary arterial hypertension have led to improvements in survival. This article reviews clinically important changes in the classification of the pulmonary hypertensive diseases, as well as the epidemiology of various forms of pulmonary hypertension. The risk factors for the development of pulmonary arterial hypertension, prognostic markers, and the effects of current therapies on survival are discussed.
Taichman
Darren B
DB
University of Pennsylvania School of Medicine, Penn Presbyterian Medical Center, 51 North 39th Street, 441 PHI Building, Philadelphia, PA 19104, USA. darren.taichman@uphs.upenn.edu
Mandel
Jess
J
D001067:Appetite Depressants / Q000627:therapeutic use; D002908:Chronic Disease; D015897:Comorbidity; D015658:HIV Infections / Q000503:physiopathology; D006801:Humans; D006976:Hypertension, Pulmonary / Q000097:blood / Q000145:classification / Q000453:epidemiology*; D011379:Prognosis; D029424:Pulmonary Disease, Chronic Obstructive / Q000453:epidemiology; D011668:Pulmonary Veno-Occlusive Disease / Q000503:physiopathology; D012307:Risk Factors
D001067:Appetite Depressants